The purpose of this disclosure is to explain how we make money without charging you for our content.
Our mission is to help people at any stage of life make smart financial decisions through research, reporting, reviews, recommendations, and tools.
Earning your trust is essential to our success, and we believe transparency is critical to creating that trust. To that end, you should know that many or all of the companies featured here are partners who advertise with us.
Our content is free because our partners pay us a referral fee if you click on links or call any of the phone numbers on our site. If you choose to interact with the content on our site, we will likely receive compensation. If you don't, we will not be compensated. Ultimately the choice is yours.
Opinions are our own and our editors and staff writers are instructed to maintain editorial integrity, but compensation along with in-depth research will determine where, how, and in what order they appear on the page.
To find out more about our editorial process and how we make money, click here.
What would you do if you owned a domain name that was suddenly all over the news? If you’re the owner of Ebola.com, the answer is sell, sell, sell.
CNBC reports that Jon Schultz, who purchased Ebola.com in 2008 for an undisclosed price, is putting the domain back on the market. And with the awareness of the disease at an all-time high, he’s looking for a six-figure payout.
“We’re already doing 5,000 page views per day just by people typing in Ebola.com to see what’s there,” Schultz told the Washington Post. “We’re getting inquiries every day about the sale of it. I have a lot of experience in this sort of domain business, and my sense is that $150,000 is reasonable.”
Indeed, Schultz has quite a bit of experience selling health-related dot-coms. He and his partner Chris Hood own Blue String Ventures, a Nevada-based company that buys generic domain names and resells them for profit. Both men seem particularly attracted to disaster-related topics. In addition to GreenCoffeeExtract.com and AfricanMango.com, Blue String is also selling Fukushima.com, BirdFlu.com, and PotassiumIodide.com.
“If you’re looking for a great name for your company, there’s an excellent chance we can help,” reads a note on the company’s website, set against a background of peaceful clouds.
As CNBC points out, it’s not unheard of for a drug company to buy a disease domain name to help market their products. Cancer.com and Obesity.com are owned by Johnson & Johnson, and Arthritis.com was bought by Pfizer. But unlike those conditions, Ebola has no treatment available to the general public, and it is unclear what business would want to be associated with a virus that has already killed thousands.
That said, Schultz has some ideas on who might be interested. “Ebola.com would be a great domain for a pharmaceutical company working on a vaccine or cure, a company selling pandemic or disaster-preparedness supplies, or a medical company wishing to provide information and advertise services,” he told CNBC in an email.
Those worried Ebola.com is a cynical attempt to make money off a health catastrophe may be comforted to know the website directs users to the donation page of Doctors Without Borders. Below that link is a selection of Amazon products about Ebola (“if people click on that link and buy a book or DVD, we get a commission on the sale,” Schultz acknowledges), followed by an advertisement for a company called Flu Armour. And of course, just below a copyright notice, is a small bit of text noting “Ebola.com Is For Sale.”